Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelins as cardiovascular peptides

E R Levin1

  • 1Department of Medicine and Pharmacology, University of California, Irvine, USA.

American Journal of Nephrology
|January 1, 1996
PubMed
Summary

Endothelin-1 (ET-1) is a potent vasoconstrictor involved in vascular diseases like hypertension and arteriosclerosis. Understanding ET-1

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane estrogen receptor α is essential for estrogen signaling in the male skeleton.

The Journal of endocrinology·2018
Same author

The role of membrane ERα signaling in bone and other major estrogen responsive tissues.

Scientific reports·2016
Same author

Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer.

Oncogene·2012
Same author

Atrial natriuretic peptide and endothelin: Interactions in the central nervous system and the periphery.

Molecular and cellular neurosciences·2009
Same author

Atrial natriuretic Peptide secretion from fetal rat diencephalon in culture.

Journal of neuroendocrinology·2009
Same author

Cell localization, physiology, and nongenomic actions of estrogen receptors.

Journal of applied physiology (Bethesda, Md. : 1985)·2001

Area of Science:

  • Vascular Biology and Medicine
  • Endocrinology
  • Cardiovascular Physiology

Background:

  • Vasoactive substances modulate vascular health, influencing hypertension and arteriosclerosis.
  • Three endothelins (ETs) identified; ET-1 is the most potent vasoconstrictor.
  • ET-1 has a short plasma half-life, enabling rapid blood pressure regulation.

Purpose of the Study:

  • To elucidate the role of endothelin-1 (ET-1) in normal and pathological vascular functions.
  • To explore ET-1's involvement in conditions like hypertension, arteriosclerosis, and diabetes.
  • To investigate potential therapeutic strategies targeting ET-1 pathways.

Main Methods:

  • Characterization of ET-1 production and receptor binding.
  • Analysis of ET-1's postreceptor signaling pathways, including MAPK cascade.
  • Investigation of factors stimulating or inhibiting ET-1 secretion (e.g., prostaglandins, hypoxia, insulin).

Main Results:

  • ET-1 is produced by various cell types and acts as a potent vasoconstrictor.
  • ET-1 signaling involves the mitogen-activated protein kinase cascade, contributing to cell growth.
  • ET-1 secretion is influenced by diverse stimuli and plays a role in nitric oxide and hormone regulation.

Conclusions:

  • ET-1 significantly impacts vascular resistance, blood pressure, and hormonal balance.
  • ET-1 is implicated in accelerated vascular disease in diabetes, asthma, pulmonary hypertension, and kidney disease.
  • Further understanding of ET-1 functions may lead to novel therapies for vascular disorders.

Related Experiment Videos